Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government
Contract award will support manufacturing of new bulk vaccine to partly replenish the inventory used for the mpox ou…
Contract award will support manufacturing of new bulk vaccine to partly replenish the inventory used for the mpox ou…
D-Konstanz | As part of the TraceBot funding project, around 50 experts from research and industry came together to disc…
Trade fair for packaging from May 4 to 10, 2023 in Düsseldorf, Germany BASF continues “Plastics Journey” for a more sust…
BluCon Biotech, a German biotech company, and LG Chem, a leading chemical company, have entered into an investment agree…
Bavarian Nordic A/S (OMX: BAVA) today published its Annual Report for 2022. The consolidated, audited results were in li…
Adds two revenue-generating vaccines for the prevention of cholera and typhoid fever that will establish Bavarian Nordic…
Datwyler increased its revenue from continuing operations by 21.4% to CHF 1'150.6 million in 2022. Adjusted for currency…
Gerresheimer presents its new Clinical Trial Kit at Pharmapack in Paris. This kit consists of sterile Gx RTF vials in ne…
Nomad Bioscience GmbH, Munich, Germany (“NOMAD”) is pleased to announce that the Company has extended its research and d…
With innovative, solution-oriented, and sustainable developments, the Gerresheimer team presents itself at Pharmapack an…